Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-34416677

RESUMO

An on-line solid phase extraction using a lab-made restricted access media (RAM) was developed as sample preparation procedure for determination of the pharmaceutical compounds caffeine (CAF), carbamazepine (CBZ), norfloxacin (NOR), ciprofloxacin (CIP), fluoxetine (FLX) and venlafaxine in wastewater treatment plant samples by liquid chromatography-tandem mass spectrometry (LC-MS/MS). This method is suitable for use in routine of analysis, avoiding cross-contamination and requiring only a small sample volume (50 µL), with minimal handling. The method was validated according to international guidelines. The chromatographic efficiency was evaluated using peak resolution and asymmetry parameters. Carryover was also evaluated, in order to ensure reliability of the analysis and the ability to reuse the cartridge. Satisfactory linearity (r2 > 0.99) was obtained for all the compounds. The intra- and inter-day precision values were lower than 5.79 and 14.1%, respectively. The limits of detection ranged from 0.01 to 3 µg L-1 and the limits of quantification were from 0.1 to 5 µg L-1. The method was applied to 20 environmental wastewater samples, with caffeine being the most widely detected compound, at the highest concentration of 392 µg L-1, while other compounds were detected in fewer samples at lower concentrations (up to 9.60 µg L-1). The lab-made modification is a cheaper option for on-line sample preparation, compared to commercially available on-line SPE cartridges and RAM columns. Moreover, a high-throughput procedure was achieved, with an analysis time of 16 min including sample preparation and chromatographic separation. The same RAM column was applied over 200 injections including method optimization, validation and application in wastewater samples without loss of analytical response.


Assuntos
Cromatografia Líquida/métodos , Preparações Farmacêuticas , Extração em Fase Sólida/métodos , Espectrometria de Massas em Tandem/métodos , Poluentes Químicos da Água , Reagentes de Laboratório , Limite de Detecção , Modelos Lineares , Preparações Farmacêuticas/análise , Preparações Farmacêuticas/química , Preparações Farmacêuticas/isolamento & purificação , Reprodutibilidade dos Testes , Águas Residuárias/química , Poluentes Químicos da Água/análise , Poluentes Químicos da Água/química , Poluentes Químicos da Água/isolamento & purificação
2.
Anal Methods ; 12(44): 5415-5423, 2020 11 28.
Artigo em Inglês | MEDLINE | ID: mdl-33125009

RESUMO

Herein, we present an approach for the analytical determination and quantification of semi-permanent hair dyes in wash water samples released during washing of dyed hair employing a liquid chromatography-tandem mass spectrometry-selected reaction monitoring (LC-MS/MS-SRM) method with electrospray ionization detection. Specifically, Basic Blue 99 (BB 99), Basic Brown 16 (BB 16), Basic Red 76 (BR 76), Basic Yellow 57 (BY 57) and Acid Violet 43 (AV 43) are hair dyes with properties known to be harmful to human health and the environment. The hair dyes are present in commercial formulation and are discharged into the effluents without fully effective treatment. The detection and quantification by the LC-MS/MS technique show a linear relationship for each studied hair dye in the concentration range from 1 to 200 ng mL-1 in aqueous solution. The limits of detection and quantification were found from 0.66 to 20 ng mL-1 and from 2.0 to 63 ng mL-1, respectively, values that are compatible with the level required in wash water analysis. The method was applied in samples collected from 5 successive washings of hair dyed with a commercial formulation using the established procedure. BB 99 and BY 57 dyes have lower fixation on the scalp and hair, showing 866 ng mL-1 and 145 ng mL-1 release on the first day of washing, respectively. The accumulation of dye and slow release after washing can lead to future problems for both the environment and living organisms.

3.
J Pharm Biomed Anal ; 172: 67-77, 2019 Aug 05.
Artigo em Inglês | MEDLINE | ID: mdl-31029802

RESUMO

A potent synthetic α2-adrenergic agonist called PT-31, (3-(2-chloro-6-fluorobenzyl)-imidazolidine-2,4-dione), was recently detected as a potential drug to be used as an adjuvant drug to treat chronic pain. The excellent pharmacological property of PT-31 highlights the importance in elucidating its metabolism, which could provide valuable information about its metabolite profile for further pharmacokinetics studies and additionally to estimate the impact of its metabolites on the efficacy, safety and elimination of PT-31. In this work, the study of the in vitro metabolism of PT-31 was initially carried out by using a liquid chromatography coupled to ion trap multiple-stage mass spectrometer (LC-IT-MSn) and a hybrid triple quadrupole/linear ion trap mass spectrometer (LC-QTrap). The production of at least three unknown oxidative metabolites was observed. Structural identification of the unknown metabolites was carried out by combination of LC-MS experiments, including selected reaction monitoring (SRM) and multi-stage full scan experiments. Further analysis of 1H-NMR led to the structural confirmation of the major metabolite. The results indicated that PT-31 was metabolized by a hydroxylation reaction in the imidazolidine-2,4-dione ring in rat and human liver microsomes, producing the metabolite 3-(2-chloro-6-fluorobenzyl)-5-hydroxyimidazolidine-2,4-dione in rat liver microsomes. A carbon hydroxylation onto the benzyl ring, produced two other minor metabolites of the PT-31 in rat liver microsomes.


Assuntos
Agonistas de Receptores Adrenérgicos alfa 2/metabolismo , Analgésicos/metabolismo , Microssomos Hepáticos/metabolismo , Agonistas de Receptores Adrenérgicos alfa 2/farmacocinética , Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico , Analgésicos/farmacocinética , Analgésicos/uso terapêutico , Animais , Dor Crônica/tratamento farmacológico , Avaliação Pré-Clínica de Medicamentos , Humanos , Imidazolidinas/metabolismo , Imidazolidinas/farmacocinética , Imidazolidinas/uso terapêutico , Espectroscopia de Ressonância Magnética , Oxirredução , Ratos , Espectrometria de Massas em Tandem
4.
Ecotoxicol Environ Saf ; 160: 114-126, 2018 Sep 30.
Artigo em Inglês | MEDLINE | ID: mdl-29793200

RESUMO

Synthetic azo dyes have increasingly become a matter of great concern as a result of the genotoxic and mutagenic potential of the products derived from azo dye biotransformation. This work evaluates the manner in which reducing enzymes produced by Escherichia coli (E. coli) act on three disperse dyes bearing azo groups, namely Disperse Red 73 (DR 73), Disperse Red 78 (DR 78), and Disperse Red 167 (DR 167). UV-Vis spectrophotometry, high-performance liquid chromatography with diode array detector (HPLC-DAD), and liquid chromatography mass spectrometry (LC-MS/MS) were applied towards the identification of the main products. Seven days of incubation of the azo dyes with the tested enzymes yielded a completely bleached solution. 3-4-Aminophenyl-ethyl-amino-propanitrile was detected following the biotransformation of both DR 73 and DR 78. 4-Nitroaniline and 2-chloro-4-nitroaniline were detected upon the biotransformation of DR 73 and DR 78, respectively. The main products derived from the biotransformation of DR 167 were dimethyl 3,3'-3-acetamido-4-aminophenyl-azanedyl-dipropanoate and 2-chloro-4-nitroaniline. The results imply that DR 73 lost the CN- substituent during the biotransformation. Furthermore, theoretical calculations were also carried out aiming at evaluating the interaction and reactivity of these compounds with DNA. Taken together, the results indicate that DR 73, DR 78, and DR 167 pose health risks and serious threats to both human beings and the environment at large as their biotransformation produces harmful compounds such as amines, which have been widely condemned by the International Agency for Research on Cancer.


Assuntos
Compostos Azo , Corantes , Escherichia coli/metabolismo , Compostos Azo/química , Compostos Azo/metabolismo , Compostos Azo/toxicidade , Biotransformação , Cromatografia Líquida de Alta Pressão , Corantes/química , Corantes/metabolismo , Corantes/toxicidade , Humanos , Simulação de Acoplamento Molecular , Espectrometria de Massas em Tandem , Xenobióticos/química , Xenobióticos/metabolismo , Xenobióticos/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA